Riken Vitamin Co., Ltd. (4526.T)

JPY 2408.0

(-1.23%)

Annual Cash Flows

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow 10.45 Billion 7.83 Billion 6.82 Billion 7.62 Billion 5.85 Billion 6.68 Billion
Net Income 8.75 Billion 7.85 Billion 20.31 Billion -7 Million -5.89 Billion 6.04 Billion
Depreciation & Amortization 3.33 Billion 3.71 Billion 3.73 Billion 3.95 Billion 4.07 Billion 3.91 Billion
Deferred income taxes - -95 Million -15.8 Billion -2.09 Billion -1.27 Billion -4.1 Billion
Stock-based compensation 71 Million 74 Million 70 Million 21 Million 27 Million 35 Million
Change in working capital -1.45 Billion -3.59 Billion -1.36 Billion 3.63 Billion -2.22 Billion 332 Million
Other non-cash items 8.41 Billion -127 Million -129 Million 2.11 Billion 11.14 Billion 470 Million
Investing Cash Flow -554 Million -2.03 Billion -3.66 Billion -2.28 Billion -4.28 Billion -3.38 Billion
Investments in PPE -3.02 Billion -2.16 Billion -3.38 Billion -3.77 Billion -5.38 Billion -3.97 Billion
Acquisitions 182 Million -13 Million -445 Million -58 Million -108 Million 1.74 Billion
Investment purchases -3.19 Billion -3.54 Billion -4.07 Billion -1.36 Billion -1.94 Billion -4.67 Billion
Sales/Maturities of investments 5.51 Billion 3.66 Billion 4.19 Billion 2.39 Billion 2.98 Billion 3.34 Billion
Other Investing Activities -35 Million 25 Million 50 Million 506 Million 175 Million 174 Million
Financing Cash Flow -7.08 Billion -4.57 Billion -7.56 Billion -180 Million -3.05 Billion -2.49 Billion
Debt repayment -1.49 Billion -2.6 Billion -14.28 Billion -2.05 Billion -2.02 Billion -2.2 Billion
Dividends payments -2.19 Billion -1.58 Billion -1.38 Billion -1.41 Billion -1.37 Billion -1.25 Billion
Common Stock Repurchased -6.36 Billion - - - -1 Million -173 Million
Common Stock Issuance - - - - 376 Million 172 Million
Other Financing Activities -22 Million -390 Million 8.1 Billion 3.28 Billion -23 Million 968 Million
Accounts receivables -2.68 Billion -1.14 Billion -947 Million 1.07 Billion 2.82 Billion 2.16 Billion
Accounts payables 1.38 Billion 456 Million 952 Million -271 Million -2.79 Billion 437 Million
Inventory -631 Million -2.45 Billion -1.42 Billion 2.67 Billion -2.16 Billion -2.55 Billion
Other working capital 482 Million -449 Million 56 Million 161 Million -79 Million 284 Million
Cash at beginning of period 16.65 Billion 15.06 Billion 18.65 Billion 13.6 Billion 15.15 Billion 14.48 Billion
Cash at end of period 20.14 Billion 16.65 Billion 15.06 Billion 18.65 Billion 13.6 Billion 15.15 Billion
Capital Expenditure -3.02 Billion -2.16 Billion -3.38 Billion -3.77 Billion -5.38 Billion -3.97 Billion
Effect of forex changes on cash 672 Million 369 Million 811 Million -105 Million -69 Million -140 Million
Net cash flow / Change in cash 3.48 Billion 1.59 Billion -3.59 Billion 5.05 Billion -1.55 Billion 669 Million
Free Cash Flow 7.42 Billion 5.66 Billion 3.44 Billion 3.85 Billion 464 Million 2.71 Billion

Cash Flow Charts